Thrombocytosis and STAT5 Activation in Chronic Myelogenous Leukemia Are Not Associated With JAK2 V617F or Calreticulin Mutations

被引：0
|
作者：
Turakhia, Samir [1 ]
Murugesan, Gurunathan [1 ]
Cotta, Claudiu [1 ]
Theil, Karl [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1519
引用
收藏
页码：382A / 382A
页数：1
相关论文
共 50 条
  • [41] JAK2 V617F ALLELE BURDEN IN CHRONIC MYELOPROLIFERATIVE DISEASES
    Skerget, Matevz
    Pajic, Tadej
    Kralj, Eva
    Vuckovic, Josko
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I57 - I61
  • [42] MOLECULAR CHARACTERIZATION OF MYELOPROLIFERATIVE NEOPLASMS WITH CONCOMITANT BCR-ABL1 AND JAK2 V617F OR CALRETICULIN MUTATIONS
    Bodor, C.
    Kiraly, P.
    Krahling, T.
    Gango, A.
    Marosvari, D.
    Masszi, T.
    Fekete, S.
    Ujj, G.
    Egyed, M.
    Farkas, P.
    Csomor, J.
    Kajtar, B.
    Bors, A.
    Tordai, A.
    Andrikovics, H.
    HAEMATOLOGICA, 2016, 101 : 551 - 551
  • [43] JAK2 V617F mutation in the provisional entity refractory anemia with ringed sideroblasts associated with marked thrombocytosis
    Duarte, M.
    Bento, C.
    Geraldes, C.
    Menezes, C.
    Casal, I.
    Ribeiro, M. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 497 - 498
  • [44] JAK2 V617F mutation causes cytokine-independent growth and tumorigenesis - Roles of STAT5 and c-Myc
    Kasahara, T.
    Funakoshi-Tago, M.
    Tago, K.
    CYTOKINE, 2012, 59 (03) : 539 - 539
  • [45] The utility of V617F JAK2 analysis for patients with erythrocytosis or thrombocytosis in the general hospital.
    Oscier, David Graham
    Jones, Amy
    Wallis, Louise
    Chacko, Joe
    Cross, Nicholas C. P.
    BLOOD, 2006, 108 (11) : 1037A - 1037A
  • [46] Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis
    W. Y. Au
    A. Fung
    A. K. Lie
    K. Y. Lam
    C. C. Lam
    Y. L. Kwong
    Annals of Hematology, 2007, 86 : 145 - 147
  • [47] Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera
    Scott, Linda M.
    Beer, Philip A.
    Bench, Anthony J.
    Erber, Wendy N.
    Green, Anthony R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (03) : 511 - 512
  • [48] Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis
    Au, W. Y.
    Fung, A.
    Lie, A. K.
    Lam, K. Y.
    Lam, C. C.
    Kwong, Y. L.
    ANNALS OF HEMATOLOGY, 2007, 86 (02) : 145 - 147
  • [49] JAK2 V617F mutation to calreticulin mutation in an essential thrombocythemia patient: A case report
    Wang, Su-Yun
    Yang, Ning
    Zhang, Li-Jun
    Cheng, Zhi-Yong
    INDIAN JOURNAL OF CANCER, 2021, 58 (03) : 431 - 433
  • [50] Aquagenic pruritus and the JAK2 V617F mutation
    Langabeer, S. E.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (03) : E33 - E33
12345